Search research articles
Contact Us
Filters
Showing results (21-30 of 92) with videos related to
Page
of 10
Sort By:
Journal of Cellular Biochemistry
|
December 17, 2009
A single deletion at position 134, 135, or 136 in the beta 7-beta 8 loop of the p51 subunit of HIV-1 RT disrupts the formation of heterodimeric enzyme
Alok Upadhyay, Nootan Pandey, Chaturbhuj A Mishra, et al.
Plos One
|
October 7, 2016
In Vitro Antibacterial Activity of Rhodanine Derivatives against Pathogenic Clinical Isolates
Ahmed AbdelKhalek, Charles R Ashby, Bhargav A Patel, et al.
European Journal of Medicinal Chemistry
|
February 28, 2012
Synthesis and SAR optimization of quinazolin-4(3H)-ones as poly(ADP-ribose)polymerase-1 inhibitors
Shridhar S Kulkarni, Satyakam Singh, Janki R Shah, et al.
Virus Genes
|
April 21, 2017
The molluscum contagiosum virus death effector domain containing protein MC160 RxDL motifs are not required for its known viral immune evasion functions
Michael Beaury, Uday Kiran Velagapudi, Sarah Weber, et al.
Marmara Pharmaceutical Journal
|
April 6, 2019
Etodolac Thiosemicarbazides: A novel class of hepatitis C virus NS5B polymerase inhibitors
Pelin Çıkla, Payal Arora, Amartya Basu, et al.
European Journal of Medicinal Chemistry
|
October 16, 2010
The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains
Diane Hardej, Charles R Ashby, Nikhil S Khadtare, et al.
European Journal of Medicinal Chemistry
|
September 7, 2011
Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition
Aaditya Bhatt, K R Gurukumar, Amartya Basu, et al.
Frontiers in Bioscience : a Journal and Virtual Library
|
May 30, 2008
4-Thiazolidinones: a novel class of hepatitis C virus NS5B polymerase inhibitors
Neerja Kaushik-Basu, Alain Bopda-Waffo, Tanaji T Talele, et al.
Expert Opinion on Therapeutic Patents
|
February 8, 2021
Recent development in the discovery of PARP inhibitors as anticancer agents: a patent update (2016-2020)
Uday Kiran Velagapudi, Bhargav A Patel, Xuwei Shao, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 1, 2013
Identification of novel PARP-1 inhibitors by structure-based virtual screening
Kevin Hannigan, Shridhar S Kulkarni, Volodymyr G Bdzhola, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 92) with videos related to
Sort By:
Page
of 10
Journal of Cellular Biochemistry
|
December 17, 2009
A single deletion at position 134, 135, or 136 in the beta 7-beta 8 loop of the p51 subunit of HIV-1 RT disrupts the formation of heterodimeric enzyme
Alok Upadhyay, Nootan Pandey, Chaturbhuj A Mishra, et al.
Plos One
|
October 7, 2016
In Vitro Antibacterial Activity of Rhodanine Derivatives against Pathogenic Clinical Isolates
Ahmed AbdelKhalek, Charles R Ashby, Bhargav A Patel, et al.
European Journal of Medicinal Chemistry
|
February 28, 2012
Synthesis and SAR optimization of quinazolin-4(3H)-ones as poly(ADP-ribose)polymerase-1 inhibitors
Shridhar S Kulkarni, Satyakam Singh, Janki R Shah, et al.
Virus Genes
|
April 21, 2017
The molluscum contagiosum virus death effector domain containing protein MC160 RxDL motifs are not required for its known viral immune evasion functions
Michael Beaury, Uday Kiran Velagapudi, Sarah Weber, et al.
Marmara Pharmaceutical Journal
|
April 6, 2019
Etodolac Thiosemicarbazides: A novel class of hepatitis C virus NS5B polymerase inhibitors
Pelin Çıkla, Payal Arora, Amartya Basu, et al.
European Journal of Medicinal Chemistry
|
October 16, 2010
The synthesis of phenylalanine-derived C5-substituted rhodanines and their activity against selected methicillin-resistant Staphylococcus aureus (MRSA) strains
Diane Hardej, Charles R Ashby, Nikhil S Khadtare, et al.
European Journal of Medicinal Chemistry
|
September 7, 2011
Synthesis and SAR optimization of diketo acid pharmacophore for HCV NS5B polymerase inhibition
Aaditya Bhatt, K R Gurukumar, Amartya Basu, et al.
Frontiers in Bioscience : a Journal and Virtual Library
|
May 30, 2008
4-Thiazolidinones: a novel class of hepatitis C virus NS5B polymerase inhibitors
Neerja Kaushik-Basu, Alain Bopda-Waffo, Tanaji T Talele, et al.
Expert Opinion on Therapeutic Patents
|
February 8, 2021
Recent development in the discovery of PARP inhibitors as anticancer agents: a patent update (2016-2020)
Uday Kiran Velagapudi, Bhargav A Patel, Xuwei Shao, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 1, 2013
Identification of novel PARP-1 inhibitors by structure-based virtual screening
Kevin Hannigan, Shridhar S Kulkarni, Volodymyr G Bdzhola, et al.
Page
of 10